HLB GLOBAL Co., Ltd. Stock

Equities

A003580

KR7003580008

Department Stores

End-of-day quote Korea S.E. 06:00:00 2024-04-21 pm EDT 5-day change 1st Jan Change
7,300 KRW +0.97% Intraday chart for HLB GLOBAL Co., Ltd. -3.44% +45.42%
Sales 2022 44.59B 32.37M Sales 2023 79.87B 57.98M Capitalization 213B 154M
Net income 2022 -11.52B -8.37M Net income 2023 -22.81B -16.56M EV / Sales 2022 5.37 x
Net Debt 2022 7.92B 5.75M Net Debt 2023 30B 21.78M EV / Sales 2023 3.04 x
P/E ratio 2022
-20 x
P/E ratio 2023
-9.33 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 91.8%
More Fundamentals * Assessed data
Dynamic Chart
HLB GLOBAL Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
HLB GLOBAL Co., Ltd. announced that it has received KRW 21.4 billion in funding from Korea Investment & Securities Co., Ltd., Emoi Co., Ltd. and other investors CI
HLB GLOBAL Co., Ltd. announced that it expects to receive KRW 21.4 billion in funding from Korea Investment & Securities Co., Ltd., Emoi Co., Ltd. and other investors CI
HLB GLOBAL Co., Ltd. completed the acquisition of TI Corporation Co., Ltd. from Tae-in Oh. CI
HLB GLOBAL Co., Ltd. agreed to acquire TI Corporation Co., Ltd. from Tae-in Oh for KRW25 billion. CI
HLB GLOBAL Co., Ltd. announced that it expects to receive KRW 14 billion in funding CI
HLB GLOBAL Co., Ltd. acquired 37.55% stake in Fresico Co., Ltd. from Jinsoo Hwang and 11 others for approximately KRW 20,392 million. CI
HLB GLOBAL Co., Ltd. announced that it has received KRW 8.208 billion in funding from Share House Gong Myeong CI
Next Science Completes Share Purchase Plan; Shares Up 3% MT
Next Science Opens Nearly $4 Million Share Purchase Plan MT
Sang-jun Lee acquired 19.9% of stake in Dongwon Resource Corporation from NEXT SCIENCE Co., Ltd. for KRW 11.4 billion. CI
G-treeBNT Co., Ltd. announced that it has received KRW 95.000054256 billion in funding from a group of investors CI
TELA Bio Receives Exclusive Rights to Sell Next Science Antimicrobial Surgical Wash in US MT
Next Science Signs Distribution Deal for Antimicrobial Cleaning Product MT
HLB Therapeutics Co.,Ltd. announced that it expects to receive KRW 95.000054256 billion in funding from a group of investors CI
More news
1 day+0.97%
1 week-3.44%
Current month-10.65%
1 month+8.47%
3 months+63.13%
6 months+96.24%
Current year+45.42%
More quotes
1 week
6 860.00
Extreme 6860
7 760.00
1 month
6 210.00
Extreme 6210
9 600.00
Current year
4 180.00
Extreme 4180
9 600.00
1 year
3 390.00
Extreme 3390
9 600.00
3 years
3 390.00
Extreme 3390
36 500.00
5 years
2 535.00
Extreme 2535
36 500.00
10 years
1 647.50
Extreme 1647.5
36 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 18-07-31
Director of Finance/CFO 55 18-07-31
Corporate Officer/Principal 43 -
Members of the board TitleAgeSince
Director/Board Member 58 19-02-28
Chief Executive Officer 59 18-07-31
Director of Finance/CFO 55 18-07-31
More insiders
Date Price Change Volume
24-04-23 7,080 -3.01% 440,574
24-04-22 7,300 +0.97% 747,602
24-04-19 7,230 -0.28% 470,019
24-04-18 7,250 +0.28% 273,859
24-04-17 7,230 -0.82% 367,873

End-of-day quote Korea S.E., April 21, 2024

More quotes
HLB Global Co Ltd, formerly Next Science Co Ltd, is a Korea-based company principally is engaged in the manufacture and sale of food and beverage. The Company operates its business through three segments. The Food and Beverage Retail Business segment is engaged in the manufacture and sale of fermented milk, confectionery, jam syrup for ice cream and fermented beverage. The Resource Business segment is engaged in the manufacture and sale of aggregates. The Cosmetics Business segment is engaged in the businesses including cosmetics manufacturing and sale, health functional food sale, among other businesses.
More about the company
  1. Stock Market
  2. Equities
  3. A003580 Stock